See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days
News Digest / StockInvest.us

Author: StockInvest.us
05:09pm, Thursday, May 01, 2025
Bio-Rad Reports Q1 2025 Results: Cash Flow Up But Sales and Profitability Decline
Bio-Rad Laboratories, Inc. (NYSE: BIO) has recently reported its financial results for Q1 2025, and there are notable positive and negative aspects to outline. Key Information from the Income Statement: Net Sales: $585.4 million (decreased by 4.2% from $610.8 million year over year). Gross Profi...
Read More